TMCnet News
Research and Markets: Global Diabetic Retinopathy Clinical Trials Report 2014DUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/bt2f5l/diabetic) has announced the addition of the "Diabetic Retinopathy Global Clinical Trials Review, H1, 2014" report to their offering. Diabetic Retinopathy Global Clinical Trials Review, H1, 2014 provides data on the Diabetic Retinopathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Diabetic Retinopathy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number f trials for the key drugs for treating Diabetic Retinopathy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts. Scope
Espy the commercial landscape of the major Universities / Institutes / Hospitals & Companies
For more information visit http://www.researchandmarkets.com/research/bt2f5l/diabetic
|